Intensity Therapeutics INTS
NASDAQ INTS
$3.42 -0.23 (-6.28%)
As of: Sep 29, 2026 · 3:55 PM EDT

Intensity Therapeutics (INTS) Accounts Payables (2022 - 2026)

Updated

Intensity Therapeutics' Accounts Payables was $1.01 million in Q2 2026, down 15.4% from $1.19 million a year earlier but up 58.6% from the prior quarter.

Analysis

Intensity Therapeutics (INTS) Accounts Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Accounts Payables at Intensity Therapeutics came in at $583,000, down 52.2% from FY2024.

  • Accounts Payables shows a three-year compound annual growth rate of -1.1% (FY2022 to FY2025).
  • In earlier years, Accounts Payables was $1.22 million in FY2024 (-60.0%), $3.05 million in FY2023 (+405.5%) and $603,000 in FY2022.
  • Quarterly Accounts Payables has moved between $358,404 (Q3 2023) and $3.05 million (Q4 2023) over five years.
  • Compared with a year earlier, Accounts Payables has declined for three straight quarters, with growth averaging 8.4% over the last eight quarters.
  • The best year-over-year quarter for Accounts Payables over five years was Q4 2023 (growth of 405.5%); the worst was Q4 2024 (a decline of 60.0%).
  • Per Business Quant data, INTS's Accounts Payables in the three quarters before Q2 2026 was $636,000 (Q1 2026), $583,000 (Q4 2025) and $1.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.22 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Intensity Therapeutics 10.75 Mn 10.75 Mn - 1.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Mn
Mar 31, 2026 636,000.00
Dec 31, 2025 583,000.00
Sep 30, 2025 1.68 Mn
Jun 30, 2025 1.19 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 540,000.00
Jun 30, 2024 1.92 Mn
Mar 31, 2024 1.22 Mn
Dec 31, 2023 3.05 Mn
Sep 30, 2023 358,404.00
Jun 30, 2023 1.58 Mn
Dec 31, 2022 603,000.00
API Access

Intensity Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=INTS&period=max&api_key=YOUR_API_KEY